KC-4240

A549-ROCK2-KO-1B2-Cell-Line

×
Please enable JavaScript in your browser to complete this form.
44158
Home » A549-ROCK2-KO-1B2-Cell-Line

Background of A549-ROCK2-KO-1B2-Cell-Line

Rho-associated protein kinase (ROCK), downstream effector of Rho GTPases, is a kind of serine-threonine protein kinase. Two mammalian ROCK homologs, ROCK1 and ROCK2, have been identified, which share 92% identity of amino acid sequence in their kinase domain and have a similar structure. In its native state, ROCK is self-suppressed by the pH domain in the carboxyl-terminal region. However, when RhoA and (or) RhoC are activated to bind to the RBD domain or the auto-inhibitory region is cleaved and removed by caspase-3 or Granzyme-B, ROCK is activated. As a well-described signaling cascade transmission, RhoA/ROCK pathway is an inhibitory cue to the growth cone by modulation of actin dynamics. Within this pathway, ROCK has a vital role on inhibitory signals for axon growth and in the regulation of cell survival. Although ROCK is ubiquitously expressed in all tissues, ROCK1 is mainly expressed in non-neuronal tissue and ROCK2 is expressed in brain and the spinal cord abundantly and improves with age.

Specifications

Catalog NumberKC-4240
Cell Line NameA549-ROCK2-KO-1B2-Cell-Line
Host Cell LineA549
DescriptionStable A549 cell line with human ROCK2 gene knockout, No.1B2
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% McCoy's 5a + 20% FBS + 10% DMSO
Propagation MediumMcCoy's 5a + 10% FBS
Selection MarkerN/A
MorphologyFibroblastoid cells growing as a monolayer
SubcultureSplit the saturated culture at a ratio of 1:3~1:6 every 2~3 days; seed out at about 1-3 x 105 cells/ml
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

A549-ROCK2-KO 1B2 cell line was generated using the CRISPR method.

Characterization

Figure 1: Characterization of A549-ROCK2-KO 1B2 cell line stable clone using PCR sequencing.

Figure 2: Characterization of A549-ROCK2-KO 1B2 cell line stable clone using RT-PCR sequencing.

Figure 3: Characterization of A549-ROCK2-KO 1B2 cell line stable clone using western blot.

Cell Resuscitation

  1. Prewarm culture medium (McCoy's 5a + 10% FBS)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split the saturated culture at a ratio of 1:3 ~ 1:6 every 2~3 days; seed out at about 1-3 x 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% McCoy's 5a + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Lu W, Wen J, Chen Z. Distinct Roles of ROCK1 and ROCK2 on the Cerebral Ischemia Injury and Subsequently Neurodegenerative Changes. Pharmacology. 2020;105(1-2):3-8. doi: 10.1159/000502914. Epub 2019 Sep 19. PMID: 31537002.
Please enable JavaScript in your browser to complete this form.